Krystal Biotech (KRYS) FCF Margin (2017 - 2026)
Krystal Biotech (KRYS) reported FCF Margin of 70.88% for Q3 2026, up 32.07 percentage points from 38.81% a year earlier and up 11.13 percentage points from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) FCF Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Krystal Biotech's FCF Margin came in at 65.96%, up 21.59 percentage points year-over-year; for FY2025, it was 48.55%, up 7.52 percentage points from FY2024.
- By year, FCF Margin came in at 41.02% in FY2024 (+239.45 pp) and -198.43% in FY2023.
- The Q3 2026 figure ranks as the highest quarterly FCF Margin in data going back to Q3 2023.
- Year over year, FCF Margin has now increased in each of the last four quarters, with an average year-over-year change of +23.97 percentage points over the last eight quarters.
- The high point for year-over-year FCF Margin in five years was Q3 2024 (a gain of 337.85 percentage points); the low point was Q3 2025 (a drop of 30.14 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 59.74% (Q2 2026), 62.92% (Q1 2026) and 70.37% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 70.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 70.88% |
| Jun 30, 2026 | 59.74% |
| Mar 31, 2026 | 62.92% |
| Dec 31, 2025 | 70.37% |
| Sep 30, 2025 | 38.81% |
| Jun 30, 2025 | 52.92% |
| Mar 31, 2025 | 28.08% |
| Dec 31, 2024 | 57.12% |
| Sep 30, 2024 | 68.95% |
| Jun 30, 2024 | -7.54% |
| Mar 31, 2024 | 32.29% |
| Dec 31, 2023 | -21.54% |
| Sep 30, 2023 | -268.90% |
| Jun 30, 2022 | -9,236.28% |
| Mar 31, 2022 | -12,717.51% |
| Dec 31, 2021 | -88,261.43% |
| Sep 30, 2021 | -44,834.92% |
| Jun 30, 2021 | -47,060.00% |
| Mar 31, 2021 | -36,748.48% |
| Dec 31, 2020 | -41,164.86% |
API Access
Krystal Biotech FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();